US Patent Issued to NOUSCOM on Sept. 29 for "Selection of cancer mutations for generation of a personalized cancer vaccine" (Italian Inventors)

ALEXANDRIA, Va., Sept. 30 -- United States Patent no. 12,749,556, issued on Sept. 29, was assigned to NOUSCOM AG (Basel, Switzerland).

"Selection of cancer mutations for generation of a personalized cancer vaccine" was invented by Alfredo Nicosia (Naples, Italy), Elisa Scarselli (Rome), Armin Lahm (Rome) and Guido Leoni (Rome).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to a method for selecting cancer neoantigens for use in a personalized vaccine. This invention relates as well to a method for constructing a vector or collection of vectors carrying the neoantigens for a personalized vaccine. This invention further relates to vector and collection of vectors comprising the per...